Current Global GMP Status and Trends With Focus …

Current Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing. Stephan Rönninger Pharma Medicines Technical Operations Global Quality & Compliance , …

  Global, Trends, Current, Medicine, 2012, Status, Current global gmp status and trends

PIC Sの概要について - jpma.or.jp

pic/sの概要について 日本製薬工業協会GMP事例研究会 2010年9月6/9日. 前田年秋. 製薬協gmp事例研2010.9.6/9

  Pic s

FIBA In Memoriam - jpma.or.jp

q3d(r1)：元素不純物(改定) -皮膚及び経皮投与pde- ich q3d（r1) ewgトピックリーダー 国立医薬品食品衛生研究所

  Ich q3d

定例記者会見 - jpma.or.jp

3 Ⅰ. 研究開発型製薬産業の基本スタンス 創薬イノベーションを実現し、 日本をはじめ世界中の患者さんに その成果を届けることにより、

ICH E10 ガイドラインに関する 統計的諸問題

部会資料 ich e10 ガイドラインに関する 統計的諸問題 平成15 年6 月 日本製薬工業協会 医薬品評価委員会 統計・dm 部会

PIC/Sの動向とGMP調査の現状 - jpma.or.jp

4 PIC／S加盟を踏まえて ⾒えてきた課題事項 1．使⽤者のリスク回避のための情報共有の構築 ①ラピッドアラート

PIC/S GMPの最新動向と PMDAの指摘事例について

pic/s gmpの最新動向と PMDAの指摘事例について. 独立行政法人医薬品医療機器総合機構. 品質管理部. 1 第43回2016年度GMP事例研究会（日本製薬工業協会）

2015 - JPMA

This file contains information concerning pharmaceutical administration, regulations, and new drug development in Japan updated annually by …

  Drug

グローバルに通用する GMP査察システムを目指し …

h22～ pic/sガイドライン 比較分析wg （h22.7～h23.5） 医薬品GMP査察手法の. 国際整合性確保に関する研究班 （四方田班

E3 Structure and Content of Clinical Study Reports

E3：Structure and Content of Clinical Study Reports （治験の総括報告書の構成と内容に関する ガイドライン） Question and Answers Document

  Study, Report, Clinical, Content, Structure, Structure and content of clinical study reports, E3 structure and content of clinical study reports

WHO EXPERT COMMITTEE ON SPECIFICATIONS …

i WHO Technical Report Series 908 WHO EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS A …

  Pharmaceutical, Specification, Preparation, On specifications for pharmaceutical preparations a

Guideline on good pharmacovigilance practices …

Guideline on good pharmacovigilance practices (GVP) – Annex I EMA/876333/2011 Page 2/14 8

  Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance

Appendix 8 Data Requirements for New Medicine …

In the case of a generic prescription medicine, the data sheet must be consistent with that of the corresponding innovator product. If applicable, any package insert/information leaflet supplied with the product must be consistent

  Sheet, Data, Requirements, Medicine, Data sheet, Data requirements for new medicine

LAMISIL ONCE 1 % CUTANEOUS SOLUTION PL …

INTRODUCTION Based on the review of the data on quality, safety and efficacy the UK granted marketing authorisations for the medicinal products Lamisil Once 1 % Cutaneous

  Solutions, Data, Safety, Cutaneous, Cutaneous solution pl

Castor-oil penetration test for paper (Revision of T …

3 / Castor-oil penetration test for paper T 462 om-01 4.2 Separatory funnel or buret, precision bore class A, with a tip of su ch diameter that 25 drops of distilled water delivered at 23º ± 1ºC will have a volume of 1 mL. The funnel or buret should be suspended with the end of the tip

  Castor, Castor oil

Tensile properties of paper and paperboard (using …

T 494 om-01 Tensile properties of paper and paperboard / 2 (using constant rate of elongation apparatus) 2. Definitions 2.1 Tensile strength, the maximum tensile force developed in a test specimen before rupture on a tensile test carried to rupture under prescribed conditions.

  Paper, Properties, Tensile, Paperboard, Tensile properties of paper and paperboard

Recommendations on the TRANSPORT OF …

- iii - FOREWORD The Recommendations on the Transport of Dange rous Goods are addressed to governments and to the international organizations concerned with safety in the transport of dangerous goods.

  Transport, Safety, Recommendations, Recommendations on the transport of

SILICA, CRYSTALLINE, by XRD (filter redeposition) …

SILICA, CRYSTALLINE, by XRD: METHOD 7500, Issue 4, dated 1 5 March 2003 - Page 3 of 9 NIOSH Manual of Analytical Methods (NMAM), Fourth Edition

  Filter, Crystalline, By xrd, Filter redeposition, Redeposition